A GRAPPA working group highlighted the importance of screening for comorbidities to guide treatment selection among patients with psoriatic arthritis. Identifying important comorbidities and their ...
There are better treatments for psoriatic arthritis (PsA) today than ever, but not everyone has the same access to them or gets equal care. That’s because of disparities, or preventable differences, ...
Psoriasis is a common skin condition that affects 125 million people worldwide, and about 30% of those living with psoriasis will also develop psoriatic arthritis. Medication has proven effective for ...
Like many chronic conditions, psoriatic arthritis (PsA) isn’t something you manage just once. Your psoriatic arthritis treatment journey might be more of a marathon than a sprint, with a few ...
Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — Guselkumab showed better efficacy in psoriasis skin clearance than most psoriatic arthritis ...
This article was originally published by Dermatology Times®. It has been lightly edited. Researchers found that treatment of psoriatic arthritis (PsA) varied depending on clinical specialization in ...
Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035" has been added to ...
Concomitant inflammatory bowel disease (IBD) negatively affects disease control and treatment response among patients with psoriatic arthritis (PsA) receiving biologic therapy, according to study ...
Joint pain, fatigue, and flares that strike without warning can make life with psoriatic arthritis challenging. Here's a ...
Pregnant women with PsA were linked to a nearly 2-fold increased risk for preterm birth compared with control pregnancies.